173TiPCambridge liquid biopsy “CALIBRATION” study: Can changes in circulating tumour DNA (ctDNA) predict durable tumour responses in patients with advanced oesophageal cancer receiving MEDI4736?
Linossi, C, Williams, A, Baird, R, Dovedi, S, Fitzgerald, R, Pacey, SVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz239.080
Date:
October, 2019
File:
PDF, 71 KB
2019